1.
实验组及对照组患者临床基线特征对比
Comparison of baseline clinical characteristics between the experimental group and the control group
| Variable | Total group n=288 |
Low score group n=48 |
Control group n=240 |
P |
| Data are expressed as Mean ± SD or as number; AF: Atrial fibrillation; NYHA: New York heart association; HCM: Hypertrophic cardiomyopathy. | ||||
| Age (year) | 56.96±8.446 | 57.77±8.159 | 56.80±8.510 | 0.468 |
| Gender male (n) | 197 | 34 | 163 | 0.692 |
| AF duration (month) | 40.636±56.608 | 44.849±42.120 | 39.794±59.118 | 0.573 |
| AF type | 0.012 | |||
| Paroxysmal | 86 | 7 | 79 | |
| Persistent | 202 | 41 | 161 | |
| NYHA class | < 0.001 | |||
| Ⅰ-Ⅱ | 271 | 36 | 235 | |
| Ⅲ-Ⅳ | 17 | 12 | 5 | |
| Hypertension | 72 | 6 | 66 | 0.028 |
| Diabetes | 8 | 1 | 7 | 748 |
| HCM | 25 | 17 | 8 | < 0.001 |
| Stroke | 0 | 0 | 0 | |
| Thrombosis location | ||||
| Left atrium | 47 | 47 | 0 | |
| Right atrium | 1 | 1 | 0 | |
| CHA2DS2-VASc score | 0.09 | |||
| 0 point | 85 | 8 | 77 | |
| 1 point | 141 | 29 | 112 | |
| 2 point | 62 | 11 | 51 | |
| Coronary heart disease | 3 | 1 | 2 | 0.436 |
| Previous ablation | 21 | 8 | 17 | 0.057 |
| Previous surgery | 9 | 7 | 2 | 0.818 |